• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

作者信息

Hirsh J, Warkentin T E, Shaughnessy S G, Anand S S, Halperin J L, Raschke R, Granger C, Ohman E M, Dalen J E

机构信息

Hamilton Civics Hospitals Research Centre, ON, Canada.

出版信息

Chest. 2001 Jan;119(1 Suppl):64S-94S. doi: 10.1378/chest.119.1_suppl.64s.

DOI:10.1378/chest.119.1_suppl.64s
PMID:11157643
Abstract
摘要

相似文献

1
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.肝素与低分子量肝素：作用机制、药代动力学、给药剂量、监测、疗效及安全性
Chest. 2001 Jan;119(1 Suppl):64S-94S. doi: 10.1378/chest.119.1_suppl.64s.
2
Mechanism of action and pharmacology of unfractionated heparin.普通肝素的作用机制与药理学
Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1094-6. doi: 10.1161/hq0701.093686.
3
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.肝素与低分子量肝素：作用机制、药代动力学、给药考量、监测、疗效及安全性
Chest. 1998 Nov;114(5 Suppl):489S-510S. doi: 10.1378/chest.114.5_supplement.489s.
4
The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.肝素、低分子量肝素、五糖及水蛭素在静脉血栓栓塞症和急性冠脉综合征治疗中的现状与未来
Semin Vasc Med. 2003 May;3(2):139-46. doi: 10.1055/s-2003-40672.
5
New-generation anticoagulants: the low molecular weight heparins.新一代抗凝剂：低分子量肝素
Ann Emerg Med. 1999 Dec;34(6):768-79. doi: 10.1016/s0196-0644(99)70104-6.
6
Venous thromboembolism: a guide to prevention and treatment.静脉血栓栓塞症：预防与治疗指南
Nurse Pract. 2005 Aug;30(8):26-9, 32-4, 39-43; quiz 44-5. doi: 10.1097/00006205-200508000-00006.
7
Venous thromboembolism and pregnancy.静脉血栓栓塞与妊娠
Obstet Gynecol Clin North Am. 2001 Sep;28(3):613-30. doi: 10.1016/s0889-8545(05)70222-9.
8
AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association.美国心脏协会科学声明：抗凝治疗指南：肝素：美国心脏协会为医疗专业人员发布的声明。
Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):E9-9. doi: 10.1161/hq0701.093520.
9
The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.低分子量肝素在不稳定型心绞痛和非ST段抬高型心肌梗死治疗中的作用
J Thromb Thrombolysis. 2001 Apr;11(2):171-4. doi: 10.1023/a:1011284902244.
10
Low molecular weight heparins: are they interchangeable? No.低分子量肝素：它们可以互换使用吗？不可以。
J Thromb Haemost. 2003 Jan;1(1):12-3. doi: 10.1046/j.1538-7836.2003.00017.x.

引用本文的文献

1
Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran - a case report and literature review.低分子量肝素诱导的血小板减少伴多部位栓塞：阿加曲班和达比加群成功治疗——病例报告及文献综述
Front Pharmacol. 2025 Jul 11;16:1573840. doi: 10.3389/fphar.2025.1573840. eCollection 2025.
2
Anticoagulant regimens for different therapeutic plasma exchange modes.不同治疗性血浆置换模式的抗凝方案。
Front Med (Lausanne). 2025 Jun 18;12:1568333. doi: 10.3389/fmed.2025.1568333. eCollection 2025.
3
Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair.
接受体外膜肺氧合的大鼠在使用因子IXa适配体-解毒剂寡核苷酸对进行抗凝和抗凝逆转后，心脏功能得到改善。
Cardiol Plus. 2025 Apr-Jun;10(2):87-98. doi: 10.1097/CP9.0000000000000122. Epub 2025 Jun 24.
4
Impact of Heparin Hemodialysis Catheter Lock on Partial Thromboplastin Time Assays in Inpatients on Therapeutic Intravenous Heparin.肝素血液透析导管封管对接受静脉注射肝素治疗的住院患者部分凝血活酶时间测定的影响
Semin Dial. 2025 Jul-Aug;38(4):282-285. doi: 10.1111/sdi.13260. Epub 2025 Jun 5.
5
Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting system.使用美国食品药品监督管理局不良事件报告系统对不同皮下抗凝剂治疗静脉血栓栓塞的安全性进行比较。
Sci Rep. 2025 May 16;15(1):17070. doi: 10.1038/s41598-025-01527-9.
6
Dose-dependent effects of heparin sodium injection in preventing peripherally inserted central catheter-related venous thrombosis during postoperative chemotherapy in non-small cell lung carcinoma patients.肝素钠注射液在非小细胞肺癌患者术后化疗期间预防经外周静脉穿刺中心静脉导管相关静脉血栓形成中的剂量依赖性效应
BMC Surg. 2025 May 2;25(1):194. doi: 10.1186/s12893-025-02925-6.
7
Padua Days on Muscle and Mobility Medicine, March 25-29, 2025, Hotel Petrarca, Euganean Thermae, Italy: Program and Abstracts.2025年3月25日至29日在意大利尤加尼温泉彼得拉克酒店举办的帕多瓦肌肉与运动医学日：议程与摘要
Eur J Transl Myol. 2025 Mar 31;35(1). doi: 10.4081/ejtm.2025.13789. Epub 2025 Mar 5.
8
Efficacy and safety of low-molecular-weight-heparin plus citrate in nephrotic syndrome during continuous kidney replacement therapy: retrospective study.低分子量肝素联合枸橼酸盐在连续性肾脏替代治疗肾病综合征中的疗效及安全性：回顾性研究
PeerJ. 2025 Feb 25;13:e18919. doi: 10.7717/peerj.18919. eCollection 2025.
9
A Modified Viscoelastic Point-of-Care Method for Rapid Quantitative Detection of Enoxaparin: A Single-Centre Observational Study.一种用于快速定量检测依诺肝素的改良即时粘弹性护理点方法：一项单中心观察性研究。
J Clin Med. 2025 Feb 17;14(4):1328. doi: 10.3390/jcm14041328.
10
2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.2024年欧洲心胸外科学会/欧洲成人先天性心脏病协会/欧洲心脏麻醉与围术期学会成人心脏手术体外循环指南。
Br J Anaesth. 2025 Apr;134(4):917-1008. doi: 10.1016/j.bja.2025.01.015. Epub 2025 Feb 14.